A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance

Diabetes

Volumn 51, Issue 2, 2002, Pages 484-492

  Ek, Ingvar ^a   Arner, Peter ^a,c   Rydén, Mikael ^a   Holm, Cecilia ^b   Thörne, Anders ^a   Hoffstedt, Johan ^a   Wahrenberg, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE CELL; ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOLYSIS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STOICHIOMETRY; VISCERA; WESTERN BLOTTING;

EID: 0036063941     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2.484     Document Type: Article

References (44)

1. Polycystic ovary syndrome
2. Insulin action in the polycystic ovary syndrome
3. The insulin-related ovarian regulatory system in health and disease
4. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism
5. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
6. Insulin resistance in polycystic ovary syndrome: Treating a phenotype without a genotype
7. Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
8. Metabolic syndrome X: A review
9. Not all fat is alike
10. The perils of portliness: Causes and consequences of visceral adiposity
11. Pathogenic role of visceral fat beta 3-adrenoceptors in obesity
12. The metabolic syndrome is related to beta-adrenoceptor sensitivity in visceral adipose tissue
13. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome
14. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance?
15. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome
16. Polycystic ovary syndrome-searching for an animal model
17. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men
18. The short insulin tolerance test for determination of insulin sensitivity: A comparison with the euglycemia clamp
19. Adipose tissue volume determinations in women by computed tomography: Technical considerations
20. Free testosterone and testosterone/SHBG index in hirsute women: A comparison of diagnostic accuracy
21. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis
22. A simple method to determine fat cell size and number in four mammalian species
23. Methods for the determination of adipose cell size in man and animals
24. Influences of variation in total energy intake and dietary composition on regulation of fat cell lipolysis in ideal-weight subjects
25. Species-specific alternative splicing generates a catalytically inactive form of human hormone-sensitive lipase
26. Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells
27. Human hormone-sensitive lipase: Expression and large-scale purification from a baculovirus/insect cell system
28. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function
29. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A
30. Compensatory regulation of Rialpha protein levels in protein kinase A mutant mice
31. Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene inducation in white adipose tissue
32. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hyperthrophy, but not in obesity
33. Subcutaneous adipose tissue metabolism in menopause: Importance of body fatness and regional fat distribution
34. The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women
35. Insulin resistance polycystic ovary syndrome and metformin
36. Nutrient modulation of cellular insulin action
37. Excessive portal venous supply of long-chain free fatty acids to the liver, leading to hypothalamus-pituitary-adrenal-axis and sympathetic activation as a key to the development of syndrome X: A proposed concept for the induction of syndrome X
38. Fatty acid regulation of gene expression: Its role in fuel partitioning and insulin resistance
39. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
40. Surgical removal of visceral fat reverses hepatic insulin resistance
41. Long-term effects of omentectomy in connection with gastric banding for obesity
42. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: Predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamster
43. Postreceptor events involved in the up-regulation of beta-adrenergic receptor mediated by testosterone in rat white adipocytes
44. Hormonal control of regional fat distribution